Omalizumab in patients with antihistamine‐resistant CSU
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.17368
Abstract: This study from France concerned itself with the biologic drug, omalizumab, as treatment for chronic spontaneous urticaria (CSU). CSU causes troublesome, even debilitating, itchy weals like nettle stings (urticaria), together with swelling of deeper tissues… read more here.
Keywords: omalizumab patients; patients antihistamine; resistant csu; study ... See more keywords
[Clinical efficacy observation of omalizumab on patients with moderate to severe allergic asthma for one year].
Sign Up to like & getrecommendations! Published in 2023 at "Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]"
DOI: 10.3760/cma.j.cn112150-20221016-00998
Abstract: To observe the symptom control, pulmonary function changes and safety of use of omalizumab in patients with moderate to severe allergic asthma for 1 year. A small sample self-controlled study before and after treatment was… read more here.
Keywords: omalizumab patients; treatment months; moderate severe; months treatment ... See more keywords